Strategic Execution and Market Dynamics

Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.

• Performance beat was driven by improved reimbursement rates, volume growth across all segments, and continued operational efficiencies from automation and AI efforts.

• The company successfully concluded a four-year advocacy campaign in California, securing a significant pediatric private duty nursing rate increase effective January 1, 2027.

• Management is pivoting the labor strategy to proactively increase nurse wages in California this fall, aiming to capture pent-up demand and facilitate hospital discharges ahead of the formal rate implementation.

• The 'Preferred Payer' strategy is nearing completion across all segments, with 64% of PDS MCO volumes now under these agreements, up from 60% in Q1.

• Home Health and Hospice growth was fueled by a strategic shift toward episodic care, which reached 81% of the mix, significantly improving margin profiles and clinical outcomes.

• The labor market is showing signs of stabilization, allowing the company to focus on cost-of-living adjustments rather than the 'catch-up' rate increases required over the past few years.

Enhanced Outlook and Long-Term Growth Framework

• Increased full-year 2026 revenue guidance to greater than $2.68 billion and adjusted EBITDA to greater than $365 million based on core organic strength.

• Raised long-term organic growth targets for Private Duty Services to 5-6% and Home Health and Hospice to 8-10%, reflecting improved visibility into state and federal rate environments.

• Management expects to return Medical Solutions to double-digit growth by the beginning of 2027 as the preferred payer transition in that segment concludes.

• The M&A strategy is shifting toward 'Aveanna 2.0,' prioritizing Home Health and Hospice acquisitions to fill geographic gaps and leverage the company's existing back-office infrastructure.

• Free cash flow is projected to remain strong at approximately $150 million for the full year, supporting a deleveraging path toward a sub-3x target by 2027.

Structural Changes and Integration Updates

• The Family First Homecare acquisition closed in June; The Family First Homecare integration is progressing nicely and as well or better than expected, with the majority of efforts expected to wrap up by late Q4. with back-office consolidation expected to wrap up by late Q4.

• Successfully repriced a term loan during Q2, reducing the interest rate by 75 basis points and lowering annual interest expense by approximately $10 million.

• Substantially all variable rate debt ($1.4 billion) is now hedged with interest rate caps to mitigate SOFR exposure.

• Management noted that while the 'Big Beautiful Bill' (OBBBA) impacts Medicaid broadly, Private Duty Nursing remains insulated due to its significant cost-savings value proposition compared to NICU care.